Crossref
Ocrelizumab labelling updated with liver injury
Reactions Weekly · 31.10.2026 · 2134 (1) · 5-5
DOI: 10.1007/s40278-026-99239-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Reactions Weekly, online erschienen am 31.10.2026. Die Arbeit nennt 1 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2026). Ocrelizumab labelling updated with liver injury. Reactions Weekly, 2134(1), 5-5. https://doi.org/10.1007/s40278-026-99239-5
Vancouver
Ocrelizumab labelling updated with liver injury. Reactions Weekly. 2026;2134(1):5-5. doi:10.1007/s40278-026-99239-5
BibTeX
@article{euvimed2026,
title = {Ocrelizumab labelling updated with liver injury},
journal = {Reactions Weekly},
year = {2026},
volume = {2134},
number = {1},
pages = {5--5},
doi = {10.1007/s40278-026-99239-5}
}
EUVIMED